Boyds is a pharmaceutical consultancy that works with pharma companies, biotechs, and spin-outs to support the development of new medicines for patient benefit. Boyds works from the very early stages to help ensure the creation of a target product profile and offers support all the way through the development cycle.

Their areas of speciality include orphan drug discovery and development as well as rare diseases.

TherapeutAix’s partnership with Boyds provides us and our clients with clinical and regulatory insight across the therapy areas we work in and access to creative options for early clinical development strategy and plans, particularly in rare disease areas.